2008 Barcelona - European Society of Human Genetics

Keyword Index
β-Catenin: P04.173
β-globin: P01.007
β-RsaI: P01.007
β-thalassemia: C08.4, P01.008, P10.28
B beta 3 integrin: P06.046
B4GALNT1: P07.123
BAALC: P04.080
BAC array CGH: P02.025
BAC clones: P04.058
bacterial infection: P06.285
balanced rearrangements: S07.2
balanced translocation: P01.251
Balkan Endemic Nephropathy: P07.015
Bannayan-Riley-Ruvalcaba syndrome:
P04.190
Baraitser-Winter syndrome: P03.31
Bardet Bidl Syndrome: P01.252
Bardet Biedl syndrome: P05.010
Bardet-Biedl syndrome: P05.011
Bartter syndrome: P05.012
basal cell carcinoma: P04.151, P04.163
BAX gene: P04.030
B-catenin: P04.100
B-cell: P04.105
BCL3 gene: P06.054
BclI polymorphism: P06.039
BclI, Tth111I polymorphisms: P01.278
BCOR gene: P01.336
BCR/ABL fusion: P04.090
BCR/ABL: P04.083
bcr-ABL: P04.084, P04.091, P04.092,
P04.135
Bdnf: P05.105
Becker muscular dystrophy: P01.225
Beckwith - Wiedemann: P02.053
Beckwith-Wiedemann syndrome: P02.055,
P08.37
Beemer-Langer: P01.142
behavioural phenotype: P02.040, P02.141
Behçet’s disease: P08.06
benign familial neonatal convulsions: C06.2
Berardinelli-Seip: P01.253
Best Care: EP13.5
beta globin gene: P01.011
Beta Talassemia: P01.012
Beta thalassemia: P01.009, P07.016
beta-globin: P01.017
beta-thalassaemia: P07.017
Beta-thalassemia intermedia: P01.013
Beta-thalassemia: P10.04, P10.05
Biallelic BRCA2: P01.254
biallelic mutations: P04.025
Bicuspid aortic valve: P01.334
Bihor county: EP10.06
Binding motif: P08.31
biobank: P08.07
biobanking: EP14.02
biochip: C10.4, P08.80
Bioinformatics: P06.040, P08.08, P08.41
biological relatedness: P06.058
biomarkers: P03.18, P03.19
BioNumerics: P08.09
biotechnology: P09.42
bipolar affective disorder: P06.261
bipolar disorder: P06.041, P06.116
Birth cohort: P07.042
birth defect: P01.145, P01.357
birth defects: P05.216
Birt-Hogg-Dube: P04.123
bisphosphonates: P10.19
bisulfite: P08.48
bladder cancer: P04.124, P04.125, P04.126,
P04.127
Bladder Transitional Cell Carcinoma:
P04.128
blastogenesis: P01.148
bleomycin sensitivity: P02.123
bleomycin: P01.332
blepharocheilodontic syndrome: P01.255
blood donation for genomic research: EPL5.3
blood pressure: P06.165
Blood Stem Cell Transplants: P08.42
blood: P07.082
blstogenesis defect: P01.357
BM: P06.057
BMP: P05.084
BMPR1A: P04.007
BMPR2 mutations: P09.56
Bone Growth: P10.24
bone malformation: P01.124
bone marrow transplantation: P04.135
Bone Mineral Density: P05.049
bone mineral parameters: P07.018
Boyadjiev-Jabs syndrome: P01.268
BPES: P02.111, P05.013
brachydactyly: P01.130
Brachymetafalangia: P02.005
brain asymmetry: P06.005
brain hemorrhage: C03.5
brain malformations: P03.74
brain: P06.078
Branchial-oto-renal syndrome: P05.015
BRCA 1: C10.6
BRCA genes: P04.031
BRCA mutations: P04.048
BRCA: EP01.02, EP01.03, EP07.1, EP13.1,
P04.041, P04.042, P08.09, P08.39
BRCA1 5382 insC: P04.041
BRCA1 gene mutation: P04.065
BRCA1/2 mutations: P04.039
BRCA1/2/X: P04.029
BRCA1/2: EP07.2, EP10.03, EP11.1,
EP12.1, EP14.03, EPL1.1, P04.044, P04.045,
P04.051
BRCA1/BRCA2 mutation carriers: S05.2
BRCA1/BRCA2: P04.040
BRCA1: C10.1, EPL1.3, P04.032, P04.033,
P04.034, P04.035, P04.036, P04.037,
P04.038, P04.043, P04.053, P04.057,
P04.067, P04.068, P04.069, P04.184,
P06.196, P07.019, P08.40, P09.01, S05.3
BRCA2: EP07.3, EPL1.3, P04.032, P04.033,
P04.034, P04.035, P04.057, P04.068,
P06.196, P07.019, P09.01, S05.3
break point: P04.084
breakpoint: P02.026, P02.112
breast and ovarian cancer syndrome:
EP10.03
breast and ovarian cancer: EPL1.3, P04.036
Breast cancer incidence: EP10.06
breast cancer subtypes: P04.029
breast cancer: C10.6, C14.4, EP07.2,
EP09.1, EP10.04, EP10.05, EP10.16,
EP11.1, EPL1.1, P01.195, P04.037, P04.039,
P04.041, P04.042, P04.043, P04.044,
P04.045, P04.046, P04.047, P04.048,
P04.049, P04.050, P04.051, P04.052,
P04.053, P04.054, P04.055, P04.056,
P04.059, P04.062, P04.063, P04.064,
P04.067, P04.180, P06.042, P07.019,
P07.020, P07.021, P08.52, S05.2, S06.1
Breast carcinoma: P04.030
Breast Ovarian Cancer: P04.035
bronchial asthma: P06.318
Brugada Syndrome: P05.177
BSCL2: P01.253, P05.016
Burkitt lymphoma: P02.171
BWS: P02.057
C syndrome: P05.020
c.1528G>C prevalent mutation: P07.076
C1 inhibitor: P05.017
C4: P06.073
C7: P06.188
Ca homeostasis: P06.321
CAD: P06.031, P06.048
CADASIL: P05.018, P07.094
cadherin: P01.247, PL2.4
Cafe-au-lait spots: P01.193
CAG repeat: P04.183
CAG repeat: P04.185
CAGE: PL3.2
Cajal-Retzius neurons: S04.2
calcinerin pathway: P06.043
CALM/AF10: C10.5
CALM: P04.085
Campomelic dysplasia: P01.150
Camptomelic dysplasia: P01.123
cancer epigenetics: P04.140
cancer genetics: EP14.06, EPL6.5
cancer risk: P02.115
Cancer Stem Cell: P04.128, P04.130
cancer syndromes: P04.131
Cancer Worry: EP10.04
cancer: EP08.5, EP10.09, EP14.04,
EP14.05, EPL3.2, P04.008, P04.122,
P04.129, P04.202, P08.10, S04.3
Candidate gene: P02.203, P06.040, P06.255
candidate genes: P02.234, P06.061,
P06.259
Cap-Analysis Gene Expression: PL3.2
capillary electrophoresis: P08.29, P08.71
Capillary malformation: C06.4
Carbohydrate: P06.212
CARD15, TNF-alpha, IL23R, ATG16L1
genes: P06.139
CARD15/NOD2: P01.344
CARD15: P06.067, P07.022
cardiac development: C04.5
cardıac ınvolvement: P01.147
cardiac remodeling: P06.043, P06.321
Cardiac screening: EP03.1